Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?

K Lauper, L Kearsley-Fleet, JB Galloway, KD Watson, KL Hyrich, M Lunt

Research output: Contribution to journal › Article › peer-review

1 results

Not started
British Society for Rheumatology Rheumatoid Arthritis Register (BSRBR-RA)
Hyrich, K. (PI), Watson, K. (Support team), Mowbray, K. (Support team), Kearsley-Fleet, L. (CoI), Lunt, M. (CoI) & Verstappen, S. (CoI)
Project: Research